ASX - By Stock
|
MSB |
Re:
News: MSB Mesoblast To Submit A Rolling Biologics License Application With FDA
|
|
AllanHU
|
14 |
5.8K |
10 |
15/01/19 |
15/01/19 |
ASX - By Stock
|
14
|
5.8K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
1 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
2 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
2 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
2 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
1 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
3 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
laughable
|
|
AllanHU
|
39 |
16K |
7 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
39
|
16K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
7 |
10/01/19 |
10/01/19 |
ASX - By Stock
|
101
|
36K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
1 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
101
|
36K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Highlights Key 2019 Priorities at U.S. Biotech Showcase
|
|
AllanHU
|
101 |
36K |
6 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
101
|
36K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
5 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
0 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
0 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
3 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
3 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
2 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
4 |
09/01/19 |
09/01/19 |
ASX - By Stock
|
63
|
25K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
10 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
63
|
25K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
3 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
63
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
4 |
08/01/19 |
08/01/19 |
ASX - By Stock
|
63
|
25K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
GVHD in US
|
|
AllanHU
|
63 |
25K |
10 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
63
|
25K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Review
|
|
AllanHU
|
49 |
24K |
8 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
49
|
24K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
AllanHU
|
3.4K |
1.3M |
2 |
20/12/18 |
20/12/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Meetings Held With FDA Support MSB's Planned GVHD Filing
|
|
AllanHU
|
71 |
26K |
6 |
13/12/18 |
13/12/18 |
ASX - By Stock
|
71
|
26K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Meetings Held With FDA Support MSB's Planned GVHD Filing
|
|
AllanHU
|
71 |
26K |
2 |
13/12/18 |
13/12/18 |
ASX - By Stock
|
71
|
26K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Any news from the AGM?
|
|
AllanHU
|
88 |
28K |
3 |
06/12/18 |
06/12/18 |
ASX - By Stock
|
88
|
28K
|
3
|
|
ASX - By Stock
|
MSB |
Takeda shareholders approve $59 billion Shire buy but are wary of debt load
|
|
AllanHU
|
0 |
415 |
1 |
05/12/18 |
05/12/18 |
ASX - By Stock
|
0
|
415
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Any news from the AGM?
|
|
AllanHU
|
88 |
28K |
3 |
29/11/18 |
29/11/18 |
ASX - By Stock
|
88
|
28K
|
3
|
|
ASX - By Stock
|
MSB |
Any news from the AGM?
|
|
AllanHU
|
88 |
28K |
0 |
29/11/18 |
29/11/18 |
ASX - By Stock
|
88
|
28K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Misunderstood Announcement
|
|
AllanHU
|
12 |
5.3K |
5 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
12
|
5.3K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Let’s not get excited about stem cells and GI bleeding
|
|
AllanHU
|
73 |
27K |
0 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
73
|
27K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Let’s not get excited about stem cells and GI bleeding
|
|
AllanHU
|
73 |
27K |
5 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
73
|
27K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB To Host Webcast For Heart Failure Results At AHA
|
|
AllanHU
|
59 |
24K |
1 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
59
|
24K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Let’s not get excited about stem cells and GI bleeding
|
|
AllanHU
|
73 |
27K |
3 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
73
|
27K
|
3
|
|
ASX - By Stock
|
MSB |
Let’s not get excited about stem cells and GI bleeding
|
|
AllanHU
|
73 |
27K |
10 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
73
|
27K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
AllanHU
|
6 |
4.3K |
7 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
6
|
4.3K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
AllanHU
|
3.4K |
1.3M |
7 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
AllanHU
|
3.4K |
1.3M |
6 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage HF Results Selected For AHA Scientific Sessions
|
|
AllanHU
|
87 |
35K |
0 |
04/10/18 |
04/10/18 |
ASX - By Stock
|
87
|
35K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage HF Results Selected For AHA Scientific Sessions
|
|
AllanHU
|
87 |
35K |
13 |
03/10/18 |
03/10/18 |
ASX - By Stock
|
87
|
35K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage HF Results Selected For AHA Scientific Sessions
|
|
AllanHU
|
87 |
35K |
0 |
03/10/18 |
03/10/18 |
ASX - By Stock
|
87
|
35K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage HF Results Selected For AHA Scientific Sessions
|
|
AllanHU
|
87 |
35K |
2 |
03/10/18 |
03/10/18 |
ASX - By Stock
|
87
|
35K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage HF Results Selected For AHA Scientific Sessions
|
|
AllanHU
|
87 |
35K |
13 |
02/10/18 |
02/10/18 |
ASX - By Stock
|
87
|
35K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: End-Stage HF Results Selected For AHA Scientific Sessions
|
|
AllanHU
|
87 |
35K |
29 |
02/10/18 |
02/10/18 |
ASX - By Stock
|
87
|
35K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
something's brewing
|
|
AllanHU
|
17 |
8.9K |
1 |
17/09/18 |
17/09/18 |
ASX - By Stock
|
17
|
8.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
something's brewing
|
|
AllanHU
|
17 |
8.9K |
6 |
16/09/18 |
16/09/18 |
ASX - By Stock
|
17
|
8.9K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
AllanHU
|
3.4K |
1.3M |
3 |
16/08/18 |
16/08/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
AllanHU
|
3.4K |
1.3M |
5 |
25/07/18 |
25/07/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
5
|
|
ASX - By Stock
|
DCC |
Re:
is it time to sell DCC?
|
|
AllanHU
|
33 |
12K |
1 |
29/06/18 |
29/06/18 |
ASX - By Stock
|
33
|
12K
|
1
|
|